By MoH of Ukraine Order No. 836 of 27.09.13, the package inserts (hereinafter – the leaflet) of the original (reference) medicinal product containing meloxicam, namely Movalis, tablets, were approved, with amendments and additions to the following sections of the leaflet: "Indications," "Contraindications," "Method of administration," "Adverse reactions," "Overdose," "Use during pregnancy or breastfeeding," "Children," "Special precautions for use," "Ability to affect reaction speed when driving vehicles or operating other machinery," "Interaction with other medicinal products and other forms of interaction."
List of medicinal products containing meloxicam authorized for medical use in Ukraine.
